查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1601247

热原测试市场：按产品类型、测试类型、最终用户划分 - 全球预测 2025-2030

Pyrogen Testing Market by Product Type (Assays, Kits, & Reagents, Instruments, Services), Test Type (Limulus Amoebocyte Lysate, Monocyte Activation Test, Rabbit Pyrogen Test), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年热原测试市场价值为12.4亿美元，预计到2024年将达到13.8亿美元，复合年增长率为11.64%，到2030年将达到26.8亿美元。

热原测试是製药和医疗设备产业的重要过程，以确保产品不含可能引起人类发烧或不良免疫反应的污染物。热原测试的需求源于严格的监管要求，以保护患者安全并确保产品功效，这对注射药物、疫苗和医疗设备等多种领域的应用做出了重大贡献。最终用途产业主要是製药、生技和医疗设备公司。影响热原检测市场的主要发展因素包括药物研发活动的增加、需要创新药物开拓的慢性疾病的快速增加以及生物製药公司的建立不断增加。此外，生物技术的进步为替代测试方法铺平了道路，例如单核细胞活化测试（MAT）等体外测试，其在伦理和技术上都优于传统的动物测试，这提供了潜在的商机。向生物製药和生物相似药的日益转变增加了对高效解决方案的需求，预计市场前景将进一步扩大。然而，这个市场面临一些限制，例如与复杂的测试方法相关的高成本以及经常延迟产品核可的复杂的法律规范。同样具有挑战性的是开发能够准确模拟体内条件的测试的技术复杂性。儘管存在这些障碍，创新领域包括开发更具成本效益、更快、更准确的体外测试方法，以及使用人工智慧和机器学习来简化流程等。热原测试市场的本质是竞争性的，重点是技术进步和收购，以扩大产品系列併提高市场占有率。寻求发展的公司可以透过策略联盟瞄准这些领域，投资新解决方案的研发，并确保遵守不断变化的监管标准，从而最大限度地降低风险并最大限度地占领市场。

主要市场统计
基准年[2023] 12.4亿美元
预测年份 [2024] 13.8亿美元
预测年份 [2030] 26.8亿美元
复合年增长率（%） 11.64%

市场动态：揭示快速发展的热原测试市场的关键市场洞察

供需的动态交互作用正在改变热原测试市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 全球感染疾病和慢性病盛行率上升
    • 增加药品、生技药品和医疗设备产品的产量
    • 全球卫生当局的严格法规和标准
  • 市场限制因素
    • 与先进的热原测试方法相关的高成本
  • 市场机会
    • 热原测试技术的技术进步
    • 供应商和製药公司合作扩大热原测试方法的部署
  • 市场挑战
    • 与热原测试相关的操作和道德问题

波特五力：驾驭热原测试市场的策略工具

波特的五力框架是了解热原测试市场竞争格局的关键工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解外部对热原测试市场的影响

外部宏观环境因素在塑造热原测试市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解热原测试市场的竞争状况

对热原测试市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵热原测试市场供应商的绩效评估

FPNV定位矩阵是评估热原测试市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议，规划热原测试市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，热原测试市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 世界各地感染疾病和慢性病的发生率正在上升
      • 增加药品、生技药品和医疗设备产品的产量
      • 世界各地卫生当局製定的严格法规和标准
    • 抑制因素
      • 与先进的热原测试方法相关的高成本
    • 机会
      • 热原测试技术的技术进步
      • 市场供应商和製药公司之间的合作扩大了热原测试方法的采用
    • 任务
      • 与热原测试相关的操作和道德问题
  • 市场区隔分析
    • 产品类型：对自动化、加速和增强测试过程的检测、套件和试剂的需求增加
    • 测试类型：由于高灵敏度和可靠性，鲎试剂测试的使用正在增加。
    • 最终用户：生技公司的热原测试采用率激增
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章热原测试市场：依产品类型

  • 测定、套件和试剂
  • 装置
  • 服务

第七章按测试类型分類的热原测试市场

  • 鲎阿米巴细胞裂解物
    • 显色试验
    • 凝胶血液凝固检验
    • 浊度测量测试
  • 单核细胞活化试验
  • 兔热原试验
  • 重组连锁试剂
  • 重组因子C

第八章热原测试市场：依最终用户分类

  • 生技公司
  • 医疗设备公司
  • 製药公司

第九章 北美和南美热原测试市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太热原测试市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲热原检测市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • FUJIFILM与 Predictive Oncology 合作改进细菌内毒素检测
    • 使用重组 C 因子检测製药用水细菌内毒素的新弹性
    • Charles River Laboratories 推出 Endsafe Trillium rCR 试剂盒，用于高效、非动物测试
    • Lonza 推出先进的快速 MAT 系统
    • Wickham Micro 扩大细菌内毒素检测设施，以满足医疗和製药行业不断增长的需求
    • MiCAN Technologies 筹集了 2 亿美元，利用创新的 MylcMAT 产品推动非动物热原测试
    • Lonza 推出了星云分光光度计，用于其品管实验室的热原和内毒素检测。
    • 新的 ISO 标准 ISO 11737-3:2023 强化了医疗产品细菌内毒素检测指南
  • 战略分析和建议
    • 诺和诺德公司
    • FUJIFILM Holdings控股有限公司
    • 沃特斯公司
    • 默克
    • 查尔斯河实验室国际有限公司

公司名单

  • Accugen Laboratories, Inc.
  • Almac Group
  • Associates of Cape Cod, Inc.
  • bioMerieux SA
  • Charles River Laboratories International, Inc.
  • Corning Incorporated
  • Creative Bioarray
  • Eurofins Scientific SE
  • FUJIFILM Holdings Corporation
  • Genscript Biotech Corporation
  • Hycult Biotechnology BV
  • IDEXX Laboratories, Inc.
  • Incell Corporation LLC
  • Indoor Biotechnologies, Inc.
  • InvivoGen SAS
  • Laboratory Corporation of America Holdings
  • Lonza Group AG
  • Lucideon Limited
  • MAT BioTech BV
  • Merck KGaA
  • Microcoat Biotechnologie GmbH
  • Minerva Biolabs GmbH
  • Nelson Laboratories, LLC by Sotera Health Company
  • North American Science Associates, LLC
  • Novo Nordisk A/S
  • Pacific Biolabs Inc.
  • QIAGEN NV
  • Solvias AG
  • Steris PLC
  • Thermo Fisher Scientific Inc.
  • Veolia Environnement SA
  • Waters Corporation
  • Wickham Micro Limited by Cormica Group
  • WuXi AppTec Co., Ltd.
Product Code: MRR-035AB9C0DA61

The Pyrogen Testing Market was valued at USD 1.24 billion in 2023, expected to reach USD 1.38 billion in 2024, and is projected to grow at a CAGR of 11.64%, to USD 2.68 billion by 2030.

Pyrogen testing is a critical process in the pharmaceutical and medical devices industries, ensuring that products are free from contaminants that can cause fever and adverse immunological responses in humans. The necessity for pyrogen testing arises from stringent regulatory mandates to safeguard patient safety and ensure product efficacy, contributing significantly to its application across diverse segments such as injectable drugs, vaccines, and medical devices. End-use industries predominantly include pharmaceuticals, biotechnology, and medical devices companies. Key growth factors influencing the pyrogen testing market include increasing pharmaceutical R&D activities, surging prevalence of chronic diseases necessitating innovative drug development, and the rise in biopharmaceutical firm establishment. Moreover, advancements in biotechnology have opened avenues for alternative testing methods, such as in vitro tests like the Monocyte Activation Test (MAT), which present potential opportunities owing to their ethical and technical advantages over traditional animal-based tests. The ongoing shift toward biologicals and biosimilars creates an extra demand for efficacious pyrogen testing solutions, offering further market prospects. However, the market faces limitations like high costs associated with advanced testing methods and complex regulatory frameworks that often delay product approvals. Challenges also include technical intricacies in developing tests that can accurately simulate in vivo conditions. Despite these hurdles, areas ripe for innovation include developing more cost-effective, faster, and precise in vitro testing methods, as well as harnessing AI and machine learning to streamline detection and analysis processes. The nature of the pyrogen testing market is competitive, with significant focus on technological advancements and acquisitions to broaden product portfolios and enhance market presence. Companies seeking growth can target these areas through strategic collaborations, investing in R&D for novel solutions, and ensuring compliance with evolving regulatory standards to minimize risks and maximize market capture.

KEY MARKET STATISTICS
Base Year [2023] USD 1.24 billion
Estimated Year [2024] USD 1.38 billion
Forecast Year [2030] USD 2.68 billion
CAGR (%) 11.64%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Pyrogen Testing Market

The Pyrogen Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising incidence of infectious and chronic diseases worldwide
    • Increasing production of pharmaceuticals, biologics, and medical device products
    • Stringent regulations and standards set by health authorities worldwide
  • Market Restraints
    • High cost associated with the advanced pyrogen testing methods
  • Market Opportunities
    • Technological advancements in pyrogen testing technologies
    • Collaboration between market vendors and pharma companies to expand the deployment of pyrogen testing methods
  • Market Challenges
    • Operational and ethical concerns associated with pyrogen testing

Porter's Five Forces: A Strategic Tool for Navigating the Pyrogen Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Pyrogen Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Pyrogen Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Pyrogen Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Pyrogen Testing Market

A detailed market share analysis in the Pyrogen Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Pyrogen Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Pyrogen Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Pyrogen Testing Market

A strategic analysis of the Pyrogen Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Pyrogen Testing Market, highlighting leading vendors and their innovative profiles. These include Accugen Laboratories, Inc., Almac Group, Associates of Cape Cod, Inc., bioMerieux SA, Charles River Laboratories International, Inc., Corning Incorporated, Creative Bioarray, Eurofins Scientific SE, FUJIFILM Holdings Corporation, Genscript Biotech Corporation, Hycult Biotechnology B.V., IDEXX Laboratories, Inc., Incell Corporation LLC, Indoor Biotechnologies, Inc., InvivoGen S.A.S., Laboratory Corporation of America Holdings, Lonza Group AG, Lucideon Limited, MAT BioTech B.V., Merck KGaA, Microcoat Biotechnologie GmbH, Minerva Biolabs GmbH, Nelson Laboratories, LLC by Sotera Health Company, North American Science Associates, LLC, Novo Nordisk A/S, Pacific Biolabs Inc., QIAGEN N.V., Solvias AG, Steris PLC, Thermo Fisher Scientific Inc., Veolia Environnement S.A., Waters Corporation, Wickham Micro Limited by Cormica Group, and WuXi AppTec Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Pyrogen Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Assays, Kits, & Reagents, Instruments, and Services.
  • Based on Test Type, market is studied across Limulus Amoebocyte Lysate, Monocyte Activation Test, Rabbit Pyrogen Test, Recombinant Cascade Reagent, and Recombinant Factor C. The Limulus Amoebocyte Lysate is further studied across Chromogenic Tests, Gel Clot Tests, and Turbidimetric Tests.
  • Based on End-User, market is studied across Biotechnology Companies, Medical Device Companies, and Pharmaceutical Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidence of infectious and chronic diseases worldwide
      • 5.1.1.2. Increasing production of pharmaceuticals, biologics, and medical device products
      • 5.1.1.3. Stringent regulations and standards set by health authorities worldwide
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with the advanced pyrogen testing methods
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in pyrogen testing technologies
      • 5.1.3.2. Collaboration between market vendors and pharma companies to expand the deployment of pyrogen testing methods
    • 5.1.4. Challenges
      • 5.1.4.1. Operational and ethical concerns associated with pyrogen testing
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product Type: Increasing need of assays, kits, & reagents to automate, facilitate, or enhance the testing processes
    • 5.2.2. Test Type: Rising usage of the LAL test due to its high sensitivity and reliability
    • 5.2.3. End-User: Burgeoning adoption of pyrogen testing across biotechnology companies
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Pyrogen Testing Market, by Product Type

  • 6.1. Introduction
  • 6.2. Assays, Kits, & Reagents
  • 6.3. Instruments
  • 6.4. Services

7. Pyrogen Testing Market, by Test Type

  • 7.1. Introduction
  • 7.2. Limulus Amoebocyte Lysate
    • 7.2.1. Chromogenic Tests
    • 7.2.2. Gel Clot Tests
    • 7.2.3. Turbidimetric Tests
  • 7.3. Monocyte Activation Test
  • 7.4. Rabbit Pyrogen Test
  • 7.5. Recombinant Cascade Reagent
  • 7.6. Recombinant Factor C

8. Pyrogen Testing Market, by End-User

  • 8.1. Introduction
  • 8.2. Biotechnology Companies
  • 8.3. Medical Device Companies
  • 8.4. Pharmaceutical Companies

9. Americas Pyrogen Testing Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Pyrogen Testing Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Pyrogen Testing Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. FUJIFILM and Predictive Oncology Partner to Improve Bacterial Endotoxin Testing
    • 12.3.2. New Flexibility for Bacterial Endotoxin Testing in Pharmaceutical Waters with Recombinant Factor C
    • 12.3.3. Charles River Laboratories Launches Endosafe Trillium rCR Cartridge for Efficient, Animal-Free Testing
    • 12.3.4. Lonza Introduces Advanced Rapid MAT Systems
    • 12.3.5. Wickham Micro Expands Bacterial Endotoxin Testing Facilities to Meet Rising Demand in Medical and Pharmaceutical Sectors
    • 12.3.6. MiCAN Technologies Raises JPY 200 Million to Advance Animal-Free Pyrogen Testing with Innovative MylcMAT Product
    • 12.3.7. Lonza Introduced the Nebula Absorbance Reader for Pyrogen and Endotoxin Testing in Quality Control Labs
    • 12.3.8. New ISO Standard ISO 11737-3:2023 Enhances Guidelines for Bacterial Endotoxin Testing in Medical Products
  • 12.4. Strategy Analysis & Recommendation
    • 12.4.1. Novo Nordisk A/S
    • 12.4.2. FUJIFILM Holdings Corporation
    • 12.4.3. Waters Corporation
    • 12.4.4. Merck KGaA
    • 12.4.5. Charles River Laboratories International, Inc.

Companies Mentioned

  • 1. Accugen Laboratories, Inc.
  • 2. Almac Group
  • 3. Associates of Cape Cod, Inc.
  • 4. bioMerieux SA
  • 5. Charles River Laboratories International, Inc.
  • 6. Corning Incorporated
  • 7. Creative Bioarray
  • 8. Eurofins Scientific SE
  • 9. FUJIFILM Holdings Corporation
  • 10. Genscript Biotech Corporation
  • 11. Hycult Biotechnology B.V.
  • 12. IDEXX Laboratories, Inc.
  • 13. Incell Corporation LLC
  • 14. Indoor Biotechnologies, Inc.
  • 15. InvivoGen S.A.S.
  • 16. Laboratory Corporation of America Holdings
  • 17. Lonza Group AG
  • 18. Lucideon Limited
  • 19. MAT BioTech B.V.
  • 20. Merck KGaA
  • 21. Microcoat Biotechnologie GmbH
  • 22. Minerva Biolabs GmbH
  • 23. Nelson Laboratories, LLC by Sotera Health Company
  • 24. North American Science Associates, LLC
  • 25. Novo Nordisk A/S
  • 26. Pacific Biolabs Inc.
  • 27. QIAGEN N.V.
  • 28. Solvias AG
  • 29. Steris PLC
  • 30. Thermo Fisher Scientific Inc.
  • 31. Veolia Environnement S.A.
  • 32. Waters Corporation
  • 33. Wickham Micro Limited by Cormica Group
  • 34. WuXi AppTec Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. PYROGEN TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. PYROGEN TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PYROGEN TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PYROGEN TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL PYROGEN TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL PYROGEN TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES PYROGEN TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES PYROGEN TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. PYROGEN TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. PYROGEN TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PYROGEN TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PYROGEN TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PYROGEN TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PYROGEN TESTING MARKET DYNAMICS
  • TABLE 7. GLOBAL PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PYROGEN TESTING MARKET SIZE, BY ASSAYS, KITS, & REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PYROGEN TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PYROGEN TESTING MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PYROGEN TESTING MARKET SIZE, BY CHROMOGENIC TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PYROGEN TESTING MARKET SIZE, BY GEL CLOT TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PYROGEN TESTING MARKET SIZE, BY TURBIDIMETRIC TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PYROGEN TESTING MARKET SIZE, BY MONOCYTE ACTIVATION TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL PYROGEN TESTING MARKET SIZE, BY RABBIT PYROGEN TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL PYROGEN TESTING MARKET SIZE, BY RECOMBINANT CASCADE REAGENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL PYROGEN TESTING MARKET SIZE, BY RECOMBINANT FACTOR C, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL PYROGEN TESTING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL PYROGEN TESTING MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL PYROGEN TESTING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES PYROGEN TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 193. PYROGEN TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 194. PYROGEN TESTING MARKET, FPNV POSITIONING MATRIX, 2023